Serum soluble urokinase plasminogen activator receptor as a screening test for the early diagnosis of hepatocellular carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|35|2|601-607

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.2, 2015-02, pp. : 601-607

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Soluble urokinase‐type plasminogen activator receptor as a putative marker of male accessory gland inflammation

By  

ANDROLOGY, Vol. 3, Iss. 6, 2015-11 ,pp. : 1054-1061

John Wiley & Sons Inc

Access to resources Recommend Favorite

Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes

By  

JOURNAL OF INTERNAL MEDICINE, Vol. 277, Iss. 3, 2015-03 ,pp. : 362-371

John Wiley & Sons Inc

Access to resources Recommend Favorite

The combined serum levels of miR‐375 and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 6, 2015-09 ,pp. : 1406-1416

John Wiley & Sons Inc

Access to resources Recommend Favorite

Circulating Levels of Urokinase-Type Plasminogen Activator (uPA) and its Soluble Receptor (suPAR) in Patients with Atopic Eczema/Dermatitis Syndrome

By Kasperska-Zajac Alicja   Rogala Barbara  

Inflammation, Vol. 29, Iss. 2-3, 2005-06 ,pp. : 90-93

Springer Publishing Company

Access to resources Recommend Favorite

Seprase, Dipeptidyl Peptidase IV and Urokinase-Type Plasminogen Activator Expression in Dysplasia and Invasive Squamous Cell Carcinoma of the Esophagus

By  

Oncology, Vol. 75, Iss. 1-2, 2008-09 ,pp. : 49-59

Karger

Access to resources Recommend Favorite